Pasar al contenido principal

MODELOS PREDICTIVOS DE REGULACION DEL RNA - APLICACIONES EN SPLICING Y CANCER

BIO2011-23920

•
Nombre agencia financiadora Ministerio de Ciencia e Innovación
Acrónimo agencia financiadora MICINN
Programa Programa Nacional de Proyectos de Investigación Fundamental
Subprograma Subprograma de Proyectos de Investigación Fundamental no Orientada
Convocatoria Proyectos I+D
Año convocatoria 2011
Plan Estatal 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Unidad de gestión Subdirección General de Proyectos de Investigación
Centro beneficiario UNIVERSITAT POMPEU FABRA CCT
Identificador persistente http://dx.doi.org/10.13039/501100004837

Resultados relacionados

Resultados totales (Incluyendo duplicados): 30
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Regulation of FAS exon definition and apoptosis by the ewing sarcoma protein

  • Paronetto, Maria Paola
  • Bernardis, Isabella
  • Volpe, Elisabetta
  • Bechara, Elias
  • Sebestyén, Endre
  • Eyras Jiménez, Eduardo
  • Valcárcel, J. (Juan)
The Ewing sarcoma protein EWS is an RNA and DNA binding protein implicated in transcription, pre-mRNA splicing, and DNA damage response. Using CLIP-seq, we identified EWS RNA binding sites in exonic regions near 5′ splice sites. A prominent target was exon 6 of the FAS/CD95 receptor, which is alternatively spliced to generate isoforms with opposing activities in programmed cell death. Depletion and overexpression experiments showed that EWS promotes exon 6 inclusion and consequently the synthesis of the proapoptotic FAS/CD95 isoform, whereas an EWS-FLI1 fusion protein characteristic of Ewing sarcomas shows decreased activity. Biochemical analyses revealed that EWS binding promotes the recruitment of U1snRNP and U2AF65 to the splice sites flanking exon 6 and therefore exon definition. Consistent with a role for EWS in the regulation of programmed cell death, cells depleted of EWS show decreased sensitivity to FAS-induced apoptosis, and elevated EWS expression enhances apoptosis in EWS-haploinsufficient Ewing sarcoma cells., M.P.P. was supported by a fellowship from the HFSP. This project was supported by Fundación Botín, Fundación Sandra Ibarra (FSI2013), the European Union Sixth Framework Programme under grant agreement Nr. LSHG-CT-2005-518238-V (EURASNET), the Spanish Ministry of Economy and Competitiveness (grant no. CSD2009-00080, Consolider RNAREG/BFU2011-29583 / BIO2011-23920), and AIRC (Grant MFAG 11658). We also acknowledge support of the Spanish Ministry of Economy and Competitiveness, “Centro de Excelencia Severo Ochoa 2013-2017” (SEV-2012-0208)
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Detection of recurrent alternative splicing switches in tumor samples reveals novel signatures of cancer

  • Sebestyén, Endre
  • Zawisza, Michal
  • Eyras Jiménez, Eduardo
The determination of the alternative splicing isoforms expressed in cancer is fundamental for the development of tumor-specific molecular targets for prognosis and therapy, but it is hindered by the heterogeneity of tumors and the variability across patients. We developed a new computational method, robust to biological and technical variability, which identifies significant transcript isoform changes across multiple samples. We applied this method to more than 4000 samples from the The Cancer Genome Atlas project to obtain novel splicing signatures that are predictive for nine different cancer types, and find a specific signature for basal-like breast tumors involving the tumor-driver CTNND1. Additionally, our method identifies 244 isoform switches, for which the change occurs in the most abundant transcript. Some of these switches occur in known tumor drivers, including PPARG, CCND3, RALGDS, MITF, PRDM1, ABI1 and MYH11, for which the switch implies a change in the protein product. Moreover, some of the switches cannot be described with simple splicing events. Surprisingly, isoform switches are independent of somatic mutations, except for the tumor-suppressor FBLN2 and the oncogene MYH11. Our method reveals novel signatures of cancer in terms of transcript isoforms specifically expressed in tumors, providing novel potential molecular targets for prognosis and therapy. Data and software are available at: http://dx.doi.org/10.6084/m9.figshare.1061917 and https://bitbucket.org/regulatorygenomicsupf/iso-ktsp., Ministerio de Ciencia e Innovación of Spain [BIO2011-23920]; Consolider RNAREG [CSD2009-00080]; Sandra Ibarra Foundation for Cancer [FSI2013]. Funding for open access charge: Ministerio de Ciencia e Innovación of Spain [BIO2011-23920]; Consolider RNAREG [CSD2009-00080]; Sandra Ibarra Foundation for Cancer [FSI2013]
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

A semi-supervised approach uncovers thousands of intragenic enhancers differentially activated in human cells

  • González-Vallinas Rostes, Juan, 1983-
  • Pagès Pinós, Amadís
  • Singh, Babita, 1986-
  • Eyras Jiménez, Eduardo
Background. Transcriptional enhancers are generally known to regulate gene transcription from afar. Their activation involves a series of changes in chromatin marks and recruitment of protein factors. These enhancers may also occur inside genes, but how many may be active in human cells and their effects on the regulation of the host gene remains unclear./nResults. We describe a novel semi-supervised method based on the relative enrichment of chromatin signals between 2 conditions to predict active enhancers. We applied this method to the tumoral K562 and the normal GM12878 cell lines to predict enhancers that are differentially active in one cell type. These predictions show enhancer-like properties according to positional distribution, correlation with gene expression and production of enhancer RNAs. Using this model, we predict 10,365 and 9777 intragenic active enhancers in K562 and GM12878, respectively, and relate the differential activation of these enhancers to expression and splicing differences of the host genes./nConclusions. We propose that the activation or silencing of intragenic transcriptional enhancers modulate the regulation of the host gene by means of a local change of the chromatin and the recruitment of enhancer-related factors that may interact with the RNA directly or through the interaction with RNA binding proteins. Predicted enhancers are available at http://regulatorygenomics.upf.edu/Projects/enhancers.html., The authors would like to thank E. Furlong, Y. Barash, B. Blencowe and U. Braunschweig for useful discussions. This work was supported by grants from Plan Nacional I + D (BIO2011-23920) and Consolider (CSD2009-00080) from MINECO (Spanish Government), and by the Sandra Ibarra Foundation for Cancer (FSI 2013). JGV and BS were supported FPI grants from the MINECO (Spanish Government) BES-2009-018064 and BES-2012-052683, respectively.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Drosha regulates gene expression independently of RNA cleavage function

  • Gromak, Natalia
  • Dienstbier, Martin
  • Macias, Sara
  • Plass Pórtulas, Mireya, 1982-
  • Eyras Jiménez, Eduardo
  • Cáceres, Javier F.
  • Proudfoot, Nicholas J.
Drosha is the main RNase III-like enzyme involved in the process of microRNA (miRNA) biogenesis in the nucleus. Using whole-genome ChIP-on-chip analysis, we demonstrate that, in addition to miRNA sequences, Drosha specifically binds promoter-proximal regions of many human genes in a transcription-dependent manner. This binding is not associated with miRNA production or RNA cleavage. Drosha knockdown in HeLa cells downregulated nascent gene transcription, resulting in a reduction of polyadenylated mRNA produced from these gene regions. Furthermore, we show that this function of Drosha is dependent on its N-terminal protein-interaction domain, which associates with the RNA-binding protein CBP80 and RNA Polymerase II. Consequently, we uncover a previously unsuspected RNA cleavage-independent function of Drosha in the regulation of human gene expression., The work was supported by a Wellcome Trust Programme Grant to N.J.P. and Royal Society University Research fellowship and MRC NIRG MR/J007870/1 to N.G. J.F.C. and S.M. were supported by the Medical Research Council and Wellcome Trust (grant 095518/Z/11/Z). E.E. was supported by grants from the Spanish Ministry of Science and by the Sandra Ibarra Foundation (BIO2008-01091, BIO2011-23920, and CSD2009-00080). M.P. is supported by the Novo Nordisk Foundation
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Leveraging transcript quantification for fast computation of alternative splicing profiles

  • Alamancos, Gael P.
  • Pagès Pinós, Amadís
  • Trincado Alonso, Juan Luis, 1987-
  • Bellora Pereyra, Nicolás
  • Eyras Jiménez, Eduardo
Alternative splicing plays an essential role in many cellular processes and bears major relevance in the understanding of multiple diseases, including cancer. High-throughput RNA sequencing allows genome-wide analyses of splicing across multiple conditions. However, the increasing number of available data sets represents a major challenge in terms of computation time and storage requirements. We describe SUPPA, a computational tool to calculate relative inclusion values of alternative splicing events, exploiting fast transcript quantification. SUPPA accuracy is comparable and sometimes superior to standard methods using simulated as well as real RNA-sequencing data compared with experimentally validated events. We assess the variability in terms of the choice of annotation and provide evidence that using complete transcripts rather than more transcripts per gene provides better estimates. Moreover, SUPPA coupled with de novo transcript reconstruction methods does not achieve accuracies as high as using quantification of known transcripts, but remains comparable to existing methods. Finally, we show that SUPPA is more than 1000 times faster than standard methods. Coupled with fast transcript quantification, SUPPA provides inclusion values at a much higher speed than existing methods without compromising accuracy, thereby facilitating the systematic splicing analysis of large data sets with limited computational resources. The software is implemented in Python 2.7 and is available under the MIT license at https://bitbucket.org/regulatorygenomicsupf/suppa., This work was supported by the Spanish Government (BIO2011-23920, CSD2009-00080), the Sandra Ibarra Foundation for Cancer (FSI-2013), and partially by the Spanish National Institute of Bioinformatics (INB)
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Predictive models of gene regulation from high-throughput epigenomics data

  • Althammer, Sonja Daniela
  • Pagès Pinós, Amadís
  • Eyras Jiménez, Eduardo
The epigenetic regulation of gene expression involves multiple factors. The synergistic or antagonistic action of these factors has suggested the existence of an epigenetic code for gene regulation. Highthroughput sequencing (HTS) provides an opportunity to explore this code and to build quantitative models of gene regulation based on epigenetic differences between specific cellular conditions. We describe a new computational framework that facilitates the systematic integration of HTS epigenetic data. Our method relates epigenetic signals to expression by comparing two conditions. We show its effectiveness by building a model that predicts with high accuracy significant expression differences between two cell lines, using epigenetic data from the ENCODE project. Our analyses provide evidence for a degenerate epigenetic code, which involves multiple genic regions. In particular, signal changes at the 1st exon, 1st intron, and downstream of the polyadenylation site are found to associate strongly with expression regulation. Our analyses also show a different epigenetic code for intron-less and intron-containing genes. Our work provides a general methodology to do integrative analysis of epigenetic differences between cellular conditions that can be applied to other studies, like cell differentiation or carcinogenesis., This work was supported by Grants BIO2011-23920 and CSD2009-00080 from the Spanish Ministry of/nScience and by the Sandra Ibarra Foundation. S. Althammer was supported by an FI grant from the Generalitat de Catalunya
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The Microprocessor controls the activity of mammalian retrotransposons

  • Heras, Sara R.
  • Macias, Sara
  • Plass Pórtulas, Mireya, 1982-
  • Fernandez, Noemí
  • Cano Ferrer, David
  • Eyras Jiménez, Eduardo
  • Garcia Perez, José L.
  • Cáceres, Javier F.
More than half of the human genome is made of transposable elements whose ongoing mobilization is a driving force in genetic diversity; however, little is known about how the host regulates their activity. Here, we show that the Microprocessor (Drosha-DGCR8), which is required for microRNA biogenesis, also recognizes and binds RNAs derived from human long interspersed element 1 (LINE-1), Alu and SVA retrotransposons. Expression analyses demonstrate that cells lacking a functional Microprocessor accumulate LINE-1 mRNA and encoded proteins. Furthermore, we show that structured regions of the LINE-1 mRNA can be cleaved in vitro by Drosha. Additionally, we used a cell culture–based assay to show that the Microprocessor negatively regulates LINE-1 and Alu retrotransposition in vivo. Altogether, these data reveal a new role for the Microprocessor as a post-transcriptional repressor of mammalian retrotransposons and a defender of human genome integrity., S.R.H. was supported by a Marie Curie Intra-European Fellowship and a Marie Curie CIG-Grant (PCIG10-GA-2011-303812). M.P. and E.E. were supported by the Spanish Ministry of Science (BIO2011-23920) and by the Sandra Ibarra Foundation (CSD2009-00080). M.P. is supported by the Novo Nordisk Foundation. J.L.G.-P. is supported by FP7-PEOPLE-2007-4-3-IRG, CICE-FEDER-P09-CTS-4980, PeS-FEDER-PI-002, FIS-FEDER-PI11/01489 and the Howard Hughes Medical Institute (IECS-55007420). J.F.C. was supported by Core funding from the Medical Research Council and by the Wellcome Trust (grant 095518/B/11/Z).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Hog1 bypasses stress-mediated down-regulation of transcription by RNA polymerase II redistribution and chromatin remodeling

  • Nadal Ribelles, Mariona, 1984-
  • Conde Pueyo, Núria, 1983-
  • Flores, Oscar
  • González-Vallinas Rostes, Juan, 1983-
  • Eyras Jiménez, Eduardo
  • Nadal Clanchet, Eulàlia de
  • Posas Garriga, Francesc
Cells are subjected to dramatic changes of gene expression upon environmental changes. Stress/ncauses a general down-regulation of gene expression together with the induction of a set of stress-responsive/ngenes. The p38-related stress-activated protein kinase Hog1 is an important regulator of transcription upon/nosmostress in yeast. Genome-wide localization studies of RNA polymerase II (RNA Pol II) and Hog1 showed that stress induced major changes in RNA Pol II localization, with a shift toward stress-responsive genes relative to housekeeping genes. RNA Pol II relocalization required Hog1, which was also localized to stress-responsive loci. In addition to RNA Pol II-bound genes, Hog1 also localized to RNA polymerase III-bound genes, pointing to a wider role for Hog1 in transcriptional control than initially expected. Interestingly, an increasing association of Hog1 with stressresponsive genes was strongly correlated with chromatin remodeling and increased gene expression. Remarkably, MNase-Seq analysis showed that although chromatin structure was not significantly altered at a genome-wide level in response to stress, there was pronounced chromatin remodeling for those genes that displayed Hog1 association. Hog1 serves to bypass the general down-regulation of gene expression that occurs in response to osmostress, and does so both by targeting RNA Pol II machinery and by inducing chromatin remodeling at stressresponsive loci., MN is a recipient of an FIS fellowship. This work was supported by grants from the Spanish Government (BIO2011-23920 to EE, BIO2009-07762 and BFU2012-33503 to FP, BFU2011-26722 to EN), the Consolider Ingenio 2010/nprogramme CSD2007-0015 to FP and FP7 UNICELLSYS grant 201142, the Fundación Marcelino Botín (FMB) to FP. EN and FP are recipients of an ICREA Acadèmia (Generalitat de Catalunya).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

A chromatin code for alternative splicing involving a putative association between CTCF and HP1alpha proteins

  • Agirre Ortiz de Guzmán, Eneritz, 1983-
  • Bellora Pereyra, Nicolás
  • Alló, Mariano
  • Pagès Pinós, Amadís
  • Bertucci, Paola
  • Kornblihtt, Alberto R.
  • Eyras Jiménez, Eduardo
BACKGROUND: Alternative splicing is primarily controlled by the activity of splicing factors and by the elongation of the RNA polymerase II (RNAPII). Recent experiments have suggested a new complex network of splicing regulation involving chromatin, transcription and multiple protein factors. In particular, the CCCTC-binding factor (CTCF), the Argonaute protein AGO1, and members of the heterochromatin protein 1 (HP1) family have been implicated in the regulation of splicing associated with chromatin and the elongation of RNAPII. These results raise the question of whether these proteins may associate at the chromatin level to modulate alternative splicing. RESULTS:Using chromatin immunoprecipitation sequencing (ChIP-Seq) data for CTCF, AGO1, HP1a, H3K27me3, H3K9me2, H3K36me3, RNAPII, total H3 and 5metC and alternative splicing arrays from two cell lines, we have analyzed the combinatorial code of their binding to chromatin in relation to the alternative splicing patterns between two cell lines, MCF7 and MCF10. Using Machine Learning techniques, we identified the changes in chromatin signals that are most significantly associated with splicing regulation between these two cell lines. Moreover, we have built a map of the chromatin signals on the pre-mRNA, that is, a chromatin-based RNA-map, which can explain 606 (68.55%) of the regulated events between MCF7 and MCF10. This chromatin code involves the presence of HP1a, CTCF, AGO1, RNAPII and histone marks around regulated exons and can differentiate patterns of skipping and inclusion. Additionally, we found a significant association of HP1a and CTCF activities around the regulated exons and a putative DNA binding site for HP1alpha. CONCLUSIONS:Our results show that a considerable number of alternative splicing events could have a chromatin-dependent regulation involving the association of HP1a and CTCF near regulated exons. Additionally, we find further evidence for the involvement of HP1a and AGO1 in chromatin-related splicing regulation., This work was partly supported by the European Alternative Splicing Network (EURASNET). Additionally, E.A, N.B, A.P. and E.E were supported by grants BIO2011-23920 and CSD2009-00080 from MINECO (Spanish Government) and by a grant from the Sandra Ibarra Foundation for Cancer; A.R.K. was supported by grants from the Agencia Nacional de Promoción de Ciencia y Tecnología of Argentina, the University of Buenos Aires, the Howard Hughes Medical Institute; and M.A. by a short term fellowships from EMBO, the Journal of Cell Science and UICC.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Systems analysis identifies melanoma-enriched pro-oncogenic networks controlled by the RNA binding protein CELF1

  • Cifdaloz, Metehan
  • Osterloh, Lisa
  • Graña-Castro, Osvaldo
  • Riveiro-Falkenbach, Erica
  • Ximénez-Embún, Pilar
  • Muñoz, Javier
  • Tejedo, Cristina
  • Calvo, Tonantzin G.
  • Karras, Panagiotis
  • Olmeda, David
  • Miñana Gómez, Belén
  • Gómez López, Gonzalo
  • Cañón, Estela
  • Eyras Jiménez, Eduardo
  • Guo, Haihong
  • Kappes, Ferdinand
  • Ortíz Romero, Pablo Luis
  • Rodríguez Peraltó, José Luís
  • Megías, Diego
  • Valcárcel, J. (Juan)
  • Soengas, María S.
Melanomas are well-known for their altered mRNA expression profiles. Yet, the specific contribution of mRNA binding proteins (mRBPs) to melanoma development remains unclear. Here we identify a cluster of melanoma-enriched genes under the control of CUGBP Elav-like family member 1 (CELF1). CELF1 was discovered with a distinct prognostic value in melanoma after mining the genomic landscape of the 692 known mRBPs across different cancer types. Genome-wide transcriptomic, proteomic, and RNA-immunoprecipitation studies, together with loss-of-function analyses in cell lines, and histopathological evaluation in clinical biopsies, revealed an intricate repertoire of CELF1-RNA interactors with minimal overlap with other malignancies. This systems approach uncovered the oncogene DEK as an unexpected target and downstream effector of CELF1. Importantly, CELF1 and DEK were found to represent early-induced melanoma genes and adverse indicators of overall patient survival. These results underscore novel roles of CELF1 in melanoma, illustrating tumor type-restricted functions of RBPs in cancer., M.S.S. was funded by Marató TVE, Consolider RNAREG (CSD2009-00080), and SAF2014-56868-R (Spanish Ministry of Economy and Innovation). J.V. was funded by Fundación Botín, Banco de Santander through its Santander Universities Global Division, Consolider RNAREG (CSD2009-00080), AGAUR and the European Research Council, and acknowledges support of the Spanish Ministry of Economy and Competitiveness, Centro de Excelencia Severo Ochoa 2013-2017. J.L.R.-P. was funded by grant FIS 2014/1737, and P.L.O.-R. by FIS 14/1784 from the Spanish Ministry of Health. E.E. was funded by grants BIO2011-23920, Consolider RNAREG (CSD2009-00080), by AGAUR (2014-SGR1121) and by the Sandra Ibarra Foundation for Cancer (FSI2013). The CNIO Proteomics Unit belongs to ProteoRed, PRB2- ISCIII, supported by grant PT13/0001. J.M. was supported by the Ramon y Cajal Programme (MINECO) RYC-2012-10651. H.G. and F.K. were funded by the China Scholarship Council, the Deutsche Forschungsgemeinschaft (DFG KA 2799/1) and the START Program of the Faculty of Medicine of the RWTH Aachen University. M.C. and P.K. were funded by predoctoral fellowships from Fundación La Caixa, and C.T. from SAF2014-56868-R. E.R.-F. was a recipient of a postdoctoral fellowship from “Fundación Científica de la Asociación Española Contra el Cáncer” and was also supported by FMM-2013/0075 of Fundacion Mutua Madrileña.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

DGCR8 HITS-CLIP reveals novel functions for the Microprocessor

  • Macias, Sara
  • Plass Pórtulas, Mireya, 1982-
  • Stajuda, Agata
  • Michlewski, Gracjan
  • Eyras Jiménez, Eduardo
  • Cáceres, Javier F.
The Drosha-DGCR8 complex (Microprocessor) is required for microRNA (miRNA) biogenesis. DGCR8 recognizes the RNA substrate, whereas Drosha functions as the endonuclease. Using high-throughput sequencing and cross-linking immunoprecipitation (HITS-CLIP) we identified RNA targets of DGCR8 in human cells. Unexpectedly, miRNAs were not the most abundant targets. DGCR8-bound RNAs also comprised several hundred mRNAs as well as small nucleolar RNAs (snoRNAs) and long noncoding RNAs. We found that the Microprocessor controlled the abundance of several mRNAs as well as of MALAT1. By contrast, DGCR8-mediated cleavage of snoRNAs was independent of Drosha, suggesting the involvement of DGCR8 in cellular complexes with other endonucleases. Binding of DGCR8 to cassette exons is a new mechanism for regulation of the relative abundance of alternatively spliced isoforms. These data provide insights in the complex role of DGCR8 in controlling the fate of several classes of RNAs., This work was supported by the Medical Research Council and by the Wellcome Trust (WT084057MA) (A.S., G.M., S.M. and J.F.C.). E.E and M.P. were supported by grants from the Spanish Ministry of Science and by the Sandra Ibarra Foundation (BIO2008-01091, BIO2011-23920 and CSD2009-00080). S.M. was the recipient of an EMBO long-term postdoctoral fellowship. J.F.C is recipient of a Wellcome Trust Senior Investigator Award (Grant 095518/Z/11/Z)
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

RNA secondary structure mediates alternative 3'ss selection in Saccharomyces cerevisiae

  • Plass Pórtulas, Mireya, 1982-
  • Codony Servat, Carles
  • Ferreira, Pedro G.
  • Vilardell, Josep
  • Eyras Jiménez, Eduardo
Alternative splicing is the mechanism by which different combinations of exons in the pre-mRNA give rise to distinct mature mRNAs. This process is mediated by splicing factors that bind the pre-mRNA and affect the recognition of its splicing signals. Saccharomyces species lack many of the regulatory factors present in metazoans. Accordingly, it is generally assumed that the amount of alternative splicing is limited. However, there is recent compelling evidence that yeast have functional alternative splicing, mainly in response to environmental conditions. We have previously shown that sequence and structure properties of the pre-mRNA could explain the selection of 3' splice sites (ss) in Saccharomyces cerevisiae. In this work, we extend our previous observations to build a computational classifier that explains most of the annotated 3'ss in the CDS and 5' UTR of this organism. Moreover, we show that the same rules can explain the selection of alternative 3'ss. Experimental validation of a number of predicted alternative 3'ss shows that their usage is low compared to annotated 3'ss. The majority of these alternative 3'ss introduce premature termination codons (PTCs), suggesting a role in expression regulation. Furthermore, a genome-wide analysis of the effect of temperature, followed by experimental validation, yields only a small number of changes, indicating that this type of regulation is not widespread. Our results are consistent with the presence of alternative 3'ss selection in yeast mediated by the pre-mRNA structure, which can be responsive to external cues, like temperature, and is possibly related to the control of gene expression., E.E. and M.P. were supported by the Spanish Ministry of Science (MICINN) with grants BIO2008-01091, BIO2011-23920, and CSD2009-00080. The work from M.P. was also partly funded by Spanish National Health Institute Carlos III. J.V. and C.C.S. were supported by BIO2008-363 (MICINN) and by CSIC-200920I195. P.G.F. was supported by SFRH/BPD/42003/2007 (FCT-PORTUGAL) and by CSD2007-1500005 (MICINN)
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The translational landscape of the splicing factor SRSF1 and its role in mitosis

  • Maslon, Magdalena M.
  • Heras, Sara R.
  • Bellora Pereyra, Nicolás
  • Eyras Jiménez, Eduardo
  • Cáceres, Javier F.
The shuttling serine/arginine rich (SR) protein SRSF1 (previously known as SF2/ASF) is a splicing regulator that also activates translation in the cytoplasm. In order to dissect the gene network that is translationally regulated by SRSF1, we performed a high-throughput deep sequencing analysis of polysomal fractions in cells overexpressing SRSF1. We identified approximately 1500 mRNAs that are translational targets of SRSF1. These include mRNAs encoding proteins involved in cell cycle regulation, such as spindle, kinetochore, and M phase proteins, which are essential for accurate chromosome segregation. Indeed, we show that translational activity of SRSF1 is required for normal mitotic progression. Furthermore, we found that mRNAs that display alternative splicing changes upon SRSF1 overexpression are also its translational targets, strongly suggesting that SRSF1 couples pre-mRNA splicing and translation. These data provide insights on the complex role of SRSF1 in the control of gene expression at multiple levels and its implications in cancer., MRC Core Funding Sara R Heras, Javier F Cáceres. Wellcome Trust Senior Investigator Award Grant 095518/Z/11/Z Magdalena M Maslon, Javier F Cáceres. Marie Curie IntraEuropean fellowship Sara R Heras. Consolider RNAReg CSD2009-00080 Nicolas Bellora, Eduardo Eyras. Ministerio de Economia y Competitividad BIO2011-23920 Nicolas Bellora, Eduardo Eyras. Sandra Ibarra Foundation FSI2011-35 Nicolas Bellora, Eduardo Eyras.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

A quantitative profiling tool for diverse genomic data types reveals potential associations between chromatin and Pre-mRNA processing

  • Kremsky, Isaac Jacob, 1983-
  • Bellora Pereyra, Nicolás
  • Eyras Jiménez, Eduardo
High-throughput sequencing, and genome-based datasets in general, are often represented as profiles centered at reference points to study the association of protein binding and other signals to particular regulatory mechanisms. Although these profiles often provide compelling evidence of these associations, they do not provide a quantitative assessment of the enrichment, which makes the comparison between signals and conditions difficult. In addition, a number of biases can confound profiles, but are rarely accounted for in the tools currently available. We present a novel computational method, ProfileSeq, for the quantitative assessment of biological profiles to provide an exact, nonparametric test that specific regions of the test profile have higher or lower signal densities than a control set. The method is applicable to high-throughput sequencing data (ChIP-Seq, GRO-Seq, CLIP-Seq, etc.) and to genome-based datasets (motifs, etc.). We validate ProfileSeq by recovering and providing a quantitative assessment of several results reported before in the literature using independent datasets. We show that input signal and mappability have confounding effects on the profile results, but that normalizing the signal by input reads can eliminate these biases while preserving the biological signal. Moreover, we apply ProfileSeq to ChIP-Seq data for transcription factors, as well as for motif and CLIP-Seq data for splicing factors. In all examples considered, the profiles were robust to biases in mappability of sequencing reads. Furthermore, analyses performed with ProfileSeq reveal a number of putative relationships between transcription factor binding to DNA and splicing factor binding to pre-mRNA, adding to the growing body of evidence relating chromatin and pre-mRNA processing. ProfileSeq provides a robust way to quantify genome-wide coordinate-based signal. Software and documentation are freely available for academic use at https://bitbucket.org/regulatorygenomicsupf/profileseq/., Support was provided by an Initial Training Network grant RNPNet (289007) from the European/nCommission [http://ec.europa.eu/research/mariecurieactions/]; grants BIO2011-23920 and/nCSD2009-00080 from Ministerio de Economía y Competitividad (MINECO) from the Spanish/nGovernment [http://www.mineco.gob.es/portal/site/mineco/]; and Fundación Sandra Ibarra de/nSolidaridad Frente al Cáncer [http://www.fundacionsandraibarra.org/]
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Nuclear matrix protein Matrin3 regulates alternative splicing and forms overlapping regulatory networks with PTB

  • Coelho, Miguel B.
  • Attig, Jan
  • Bellora Pereyra, Nicolás
  • König, Julian
  • Hallegger, Martina
  • Kayikci, Melis
  • Eyras Jiménez, Eduardo
  • Ule, Jernej
  • Smith, Christopher, W. J.
Matrin3 is an RNA- and DNA-binding nuclear matrix protein found to be associated with neural and muscular degenerative diseases. A number of possible functions of Matrin3 have been suggested, but no widespread role in RNA metabolism has yet been clearly demonstrated. We identified Matrin3 by its interaction with the second RRM domain of the splicing regulator PTB. Using a combination of RNAi knockdown, transcriptome profiling and iCLIP, we find that Matrin3 is a regulator of hundreds of alternative splicing events, principally acting as a splicing repressor with only a small proportion of targeted events being co-regulated by PTB. In contrast to other splicing regulators, Matrin3 binds to an extended region within repressed exons and flanking introns with no sharply defined peaks. The identification of this clear molecular function of Matrin3 should help to clarify the molecular pathology of ALS and other diseases caused by mutations of Matrin3., This work was supported by Wellcome Trust programme grants to CWJS (077877 and 092900) and by grants to EE and NB BIO2011-23920 and RNAREG (CSD2009-00080) from the Spanish Government and by the Sandra Ibarra Foundation for Cancer (FSI 2013). JA was supported by a Boehringer Ingelheim Fonds studentship
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The Microprocessor controls the activity of mammalian retrotransposons

  • Heras, Sara R.
  • Macias, Sara
  • Plass Pórtulas, Mireya, 1982-
  • Fernandez, Noemí
  • Cano Ferrer, David
  • Eyras Jiménez, Eduardo
  • Garcia Perez, José L.
  • Cáceres, Javier F.
More than half of the human genome is made of transposable elements whose ongoing mobilization is a driving force in genetic diversity; however, little is known about how the host regulates their activity. Here, we show that the Microprocessor (Drosha-DGCR8), which is required for microRNA biogenesis, also recognizes and binds RNAs derived from human long interspersed element 1 (LINE-1), Alu and SVA retrotransposons. Expression analyses demonstrate that cells lacking a functional Microprocessor accumulate LINE-1 mRNA and encoded proteins. Furthermore, we show that structured regions of the LINE-1 mRNA can be cleaved in vitro by Drosha. Additionally, we used a cell culture–based assay to show that the Microprocessor negatively regulates LINE-1 and Alu retrotransposition in vivo. Altogether, these data reveal a new role for the Microprocessor as a post-transcriptional repressor of mammalian retrotransposons and a defender of human genome integrity., S.R.H. was supported by a Marie Curie Intra-European Fellowship and a Marie Curie CIG-Grant (PCIG10-GA-2011-303812). M.P. and E.E. were supported by the Spanish Ministry of Science (BIO2011-23920) and by the Sandra Ibarra Foundation (CSD2009-00080). M.P. is supported by the Novo Nordisk Foundation. J.L.G.-P. is supported by FP7-PEOPLE-2007-4-3-IRG, CICE-FEDER-P09-CTS-4980, PeS-FEDER-PI-002, FIS-FEDER-PI11/01489 and the Howard Hughes Medical Institute (IECS-55007420). J.F.C. was supported by Core funding from the Medical Research Council and by the Wellcome Trust (grant 095518/B/11/Z).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Drosha regulates gene expression independently of RNA cleavage function

  • Gromak, Natalia
  • Dienstbier, Martin
  • Macias, Sara
  • Plass Pórtulas, Mireya, 1982-
  • Eyras Jiménez, Eduardo
  • Cáceres, Javier F.
  • Proudfoot, Nicholas J.
Drosha is the main RNase III-like enzyme involved in the process of microRNA (miRNA) biogenesis in the nucleus. Using whole-genome ChIP-on-chip analysis, we demonstrate that, in addition to miRNA sequences, Drosha specifically binds promoter-proximal regions of many human genes in a transcription-dependent manner. This binding is not associated with miRNA production or RNA cleavage. Drosha knockdown in HeLa cells downregulated nascent gene transcription, resulting in a reduction of polyadenylated mRNA produced from these gene regions. Furthermore, we show that this function of Drosha is dependent on its N-terminal protein-interaction domain, which associates with the RNA-binding protein CBP80 and RNA Polymerase II. Consequently, we uncover a previously unsuspected RNA cleavage-independent function of Drosha in the regulation of human gene expression., The work was supported by a Wellcome Trust Programme Grant to N.J.P. and Royal Society University Research fellowship and MRC NIRG MR/J007870/1 to N.G. J.F.C. and S.M. were supported by the Medical Research Council and Wellcome Trust (grant 095518/Z/11/Z). E.E. was supported by grants from the Spanish Ministry of Science and by the Sandra Ibarra Foundation (BIO2008-01091, BIO2011-23920, and CSD2009-00080). M.P. is supported by the Novo Nordisk Foundation
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

DGCR8 HITS-CLIP reveals novel functions for the Microprocessor

  • Macias, Sara
  • Plass Pórtulas, Mireya, 1982-
  • Stajuda, Agata
  • Michlewski, Gracjan
  • Eyras Jiménez, Eduardo
  • Cáceres, Javier F.
The Drosha-DGCR8 complex (Microprocessor) is required for microRNA (miRNA) biogenesis. DGCR8 recognizes the RNA substrate, whereas Drosha functions as the endonuclease. Using high-throughput sequencing and cross-linking immunoprecipitation (HITS-CLIP) we identified RNA targets of DGCR8 in human cells. Unexpectedly, miRNAs were not the most abundant targets. DGCR8-bound RNAs also comprised several hundred mRNAs as well as small nucleolar RNAs (snoRNAs) and long noncoding RNAs. We found that the Microprocessor controlled the abundance of several mRNAs as well as of MALAT1. By contrast, DGCR8-mediated cleavage of snoRNAs was independent of Drosha, suggesting the involvement of DGCR8 in cellular complexes with other endonucleases. Binding of DGCR8 to cassette exons is a new mechanism for regulation of the relative abundance of alternatively spliced isoforms. These data provide insights in the complex role of DGCR8 in controlling the fate of several classes of RNAs., This work was supported by the Medical Research Council and by the Wellcome Trust (WT084057MA) (A.S., G.M., S.M. and J.F.C.). E.E and M.P. were supported by grants from the Spanish Ministry of Science and by the Sandra Ibarra Foundation (BIO2008-01091, BIO2011-23920 and CSD2009-00080). S.M. was the recipient of an EMBO long-term postdoctoral fellowship. J.F.C is recipient of a Wellcome Trust Senior Investigator Award (Grant 095518/Z/11/Z)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Leveraging transcript quantification for fast computation of alternative splicing profiles

  • Alamancos, Gael P.
  • Pagès Pinós, Amadís
  • Trincado Alonso, Juan Luis, 1987-
  • Bellora Pereyra, Nicolás
  • Eyras Jiménez, Eduardo
Alternative splicing plays an essential role in many cellular processes and bears major relevance in the understanding of multiple diseases, including cancer. High-throughput RNA sequencing allows genome-wide analyses of splicing across multiple conditions. However, the increasing number of available data sets represents a major challenge in terms of computation time and storage requirements. We describe SUPPA, a computational tool to calculate relative inclusion values of alternative splicing events, exploiting fast transcript quantification. SUPPA accuracy is comparable and sometimes superior to standard methods using simulated as well as real RNA-sequencing data compared with experimentally validated events. We assess the variability in terms of the choice of annotation and provide evidence that using complete transcripts rather than more transcripts per gene provides better estimates. Moreover, SUPPA coupled with de novo transcript reconstruction methods does not achieve accuracies as high as using quantification of known transcripts, but remains comparable to existing methods. Finally, we show that SUPPA is more than 1000 times faster than standard methods. Coupled with fast transcript quantification, SUPPA provides inclusion values at a much higher speed than existing methods without compromising accuracy, thereby facilitating the systematic splicing analysis of large data sets with limited computational resources. The software is implemented in Python 2.7 and is available under the MIT license at https://bitbucket.org/regulatorygenomicsupf/suppa., This work was supported by the Spanish Government (BIO2011-23920, CSD2009-00080), the Sandra Ibarra Foundation for Cancer (FSI-2013), and partially by the Spanish National Institute of Bioinformatics (INB)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Systems analysis identifies melanoma-enriched pro-oncogenic networks controlled by the RNA binding protein CELF1

  • Cifdaloz, Metehan
  • Osterloh, Lisa
  • Graña-Castro, Osvaldo
  • Riveiro-Falkenbach, Erica
  • Ximénez-Embún, Pilar
  • Muñoz, Javier
  • Tejedo, Cristina
  • Calvo, Tonantzin G.
  • Karras, Panagiotis
  • Olmeda, David
  • Miñana Gómez, Belén
  • Gómez López, Gonzalo
  • Cañón, Estela
  • Eyras Jiménez, Eduardo
  • Guo, Haihong
  • Kappes, Ferdinand
  • Ortíz Romero, Pablo Luis
  • Rodríguez Peraltó, José Luís
  • Megías, Diego
  • Valcárcel, J. (Juan)
  • Soengas, María S.
Melanomas are well-known for their altered mRNA expression profiles. Yet, the specific contribution of mRNA binding proteins (mRBPs) to melanoma development remains unclear. Here we identify a cluster of melanoma-enriched genes under the control of CUGBP Elav-like family member 1 (CELF1). CELF1 was discovered with a distinct prognostic value in melanoma after mining the genomic landscape of the 692 known mRBPs across different cancer types. Genome-wide transcriptomic, proteomic, and RNA-immunoprecipitation studies, together with loss-of-function analyses in cell lines, and histopathological evaluation in clinical biopsies, revealed an intricate repertoire of CELF1-RNA interactors with minimal overlap with other malignancies. This systems approach uncovered the oncogene DEK as an unexpected target and downstream effector of CELF1. Importantly, CELF1 and DEK were found to represent early-induced melanoma genes and adverse indicators of overall patient survival. These results underscore novel roles of CELF1 in melanoma, illustrating tumor type-restricted functions of RBPs in cancer., M.S.S. was funded by Marató TVE, Consolider RNAREG (CSD2009-00080), and SAF2014-56868-R (Spanish Ministry of Economy and Innovation). J.V. was funded by Fundación Botín, Banco de Santander through its Santander Universities Global Division, Consolider RNAREG (CSD2009-00080), AGAUR and the European Research Council, and acknowledges support of the Spanish Ministry of Economy and Competitiveness, Centro de Excelencia Severo Ochoa 2013-2017. J.L.R.-P. was funded by grant FIS 2014/1737, and P.L.O.-R. by FIS 14/1784 from the Spanish Ministry of Health. E.E. was funded by grants BIO2011-23920, Consolider RNAREG (CSD2009-00080), by AGAUR (2014-SGR1121) and by the Sandra Ibarra Foundation for Cancer (FSI2013). The CNIO Proteomics Unit belongs to ProteoRed, PRB2- ISCIII, supported by grant PT13/0001. J.M. was supported by the Ramon y Cajal Programme (MINECO) RYC-2012-10651. H.G. and F.K. were funded by the China Scholarship Council, the Deutsche Forschungsgemeinschaft (DFG KA 2799/1) and the START Program of the Faculty of Medicine of the RWTH Aachen University. M.C. and P.K. were funded by predoctoral fellowships from Fundación La Caixa, and C.T. from SAF2014-56868-R. E.R.-F. was a recipient of a postdoctoral fellowship from “Fundación Científica de la Asociación Española Contra el Cáncer” and was also supported by FMM-2013/0075 of Fundacion Mutua Madrileña.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

RNA secondary structure mediates alternative 3'ss selection in Saccharomyces cerevisiae

  • Plass Pórtulas, Mireya, 1982-
  • Codony Servat, Carles
  • Ferreira, Pedro G.
  • Vilardell, Josep
  • Eyras Jiménez, Eduardo
Alternative splicing is the mechanism by which different combinations of exons in the pre-mRNA give rise to distinct mature mRNAs. This process is mediated by splicing factors that bind the pre-mRNA and affect the recognition of its splicing signals. Saccharomyces species lack many of the regulatory factors present in metazoans. Accordingly, it is generally assumed that the amount of alternative splicing is limited. However, there is recent compelling evidence that yeast have functional alternative splicing, mainly in response to environmental conditions. We have previously shown that sequence and structure properties of the pre-mRNA could explain the selection of 3' splice sites (ss) in Saccharomyces cerevisiae. In this work, we extend our previous observations to build a computational classifier that explains most of the annotated 3'ss in the CDS and 5' UTR of this organism. Moreover, we show that the same rules can explain the selection of alternative 3'ss. Experimental validation of a number of predicted alternative 3'ss shows that their usage is low compared to annotated 3'ss. The majority of these alternative 3'ss introduce premature termination codons (PTCs), suggesting a role in expression regulation. Furthermore, a genome-wide analysis of the effect of temperature, followed by experimental validation, yields only a small number of changes, indicating that this type of regulation is not widespread. Our results are consistent with the presence of alternative 3'ss selection in yeast mediated by the pre-mRNA structure, which can be responsive to external cues, like temperature, and is possibly related to the control of gene expression., E.E. and M.P. were supported by the Spanish Ministry of Science (MICINN) with grants BIO2008-01091, BIO2011-23920, and CSD2009-00080. The work from M.P. was also partly funded by Spanish National Health Institute Carlos III. J.V. and C.C.S. were supported by BIO2008-363 (MICINN) and by CSIC-200920I195. P.G.F. was supported by SFRH/BPD/42003/2007 (FCT-PORTUGAL) and by CSD2007-1500005 (MICINN)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Hog1 bypasses stress-mediated down-regulation of transcription by RNA polymerase II redistribution and chromatin remodeling

  • Nadal Ribelles, Mariona, 1984-
  • Conde Pueyo, Núria, 1983-
  • Flores, Oscar
  • González-Vallinas Rostes, Juan, 1983-
  • Eyras Jiménez, Eduardo
  • Nadal Clanchet, Eulàlia de
  • Posas Garriga, Francesc
Cells are subjected to dramatic changes of gene expression upon environmental changes. Stress/ncauses a general down-regulation of gene expression together with the induction of a set of stress-responsive/ngenes. The p38-related stress-activated protein kinase Hog1 is an important regulator of transcription upon/nosmostress in yeast. Genome-wide localization studies of RNA polymerase II (RNA Pol II) and Hog1 showed that stress induced major changes in RNA Pol II localization, with a shift toward stress-responsive genes relative to housekeeping genes. RNA Pol II relocalization required Hog1, which was also localized to stress-responsive loci. In addition to RNA Pol II-bound genes, Hog1 also localized to RNA polymerase III-bound genes, pointing to a wider role for Hog1 in transcriptional control than initially expected. Interestingly, an increasing association of Hog1 with stressresponsive genes was strongly correlated with chromatin remodeling and increased gene expression. Remarkably, MNase-Seq analysis showed that although chromatin structure was not significantly altered at a genome-wide level in response to stress, there was pronounced chromatin remodeling for those genes that displayed Hog1 association. Hog1 serves to bypass the general down-regulation of gene expression that occurs in response to osmostress, and does so both by targeting RNA Pol II machinery and by inducing chromatin remodeling at stressresponsive loci., MN is a recipient of an FIS fellowship. This work was supported by grants from the Spanish Government (BIO2011-23920 to EE, BIO2009-07762 and BFU2012-33503 to FP, BFU2011-26722 to EN), the Consolider Ingenio 2010/nprogramme CSD2007-0015 to FP and FP7 UNICELLSYS grant 201142, the Fundación Marcelino Botín (FMB) to FP. EN and FP are recipients of an ICREA Acadèmia (Generalitat de Catalunya).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Nuclear matrix protein Matrin3 regulates alternative splicing and forms overlapping regulatory networks with PTB

  • Coelho, Miguel B.
  • Attig, Jan
  • Bellora Pereyra, Nicolás
  • König, Julian
  • Hallegger, Martina
  • Kayikci, Melis
  • Eyras Jiménez, Eduardo
  • Ule, Jernej
  • Smith, Christopher, W. J.
Matrin3 is an RNA- and DNA-binding nuclear matrix protein found to be associated with neural and muscular degenerative diseases. A number of possible functions of Matrin3 have been suggested, but no widespread role in RNA metabolism has yet been clearly demonstrated. We identified Matrin3 by its interaction with the second RRM domain of the splicing regulator PTB. Using a combination of RNAi knockdown, transcriptome profiling and iCLIP, we find that Matrin3 is a regulator of hundreds of alternative splicing events, principally acting as a splicing repressor with only a small proportion of targeted events being co-regulated by PTB. In contrast to other splicing regulators, Matrin3 binds to an extended region within repressed exons and flanking introns with no sharply defined peaks. The identification of this clear molecular function of Matrin3 should help to clarify the molecular pathology of ALS and other diseases caused by mutations of Matrin3., This work was supported by Wellcome Trust programme grants to CWJS (077877 and 092900) and by grants to EE and NB BIO2011-23920 and RNAREG (CSD2009-00080) from the Spanish Government and by the Sandra Ibarra Foundation for Cancer (FSI 2013). JA was supported by a Boehringer Ingelheim Fonds studentship
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A chromatin code for alternative splicing involving a putative association between CTCF and HP1alpha proteins

  • Agirre Ortiz de Guzmán, Eneritz, 1983-
  • Bellora Pereyra, Nicolás
  • Alló, Mariano
  • Pagès Pinós, Amadís
  • Bertucci, Paola
  • Kornblihtt, Alberto R.
  • Eyras Jiménez, Eduardo
BACKGROUND: Alternative splicing is primarily controlled by the activity of splicing factors and by the elongation of the RNA polymerase II (RNAPII). Recent experiments have suggested a new complex network of splicing regulation involving chromatin, transcription and multiple protein factors. In particular, the CCCTC-binding factor (CTCF), the Argonaute protein AGO1, and members of the heterochromatin protein 1 (HP1) family have been implicated in the regulation of splicing associated with chromatin and the elongation of RNAPII. These results raise the question of whether these proteins may associate at the chromatin level to modulate alternative splicing. RESULTS:Using chromatin immunoprecipitation sequencing (ChIP-Seq) data for CTCF, AGO1, HP1a, H3K27me3, H3K9me2, H3K36me3, RNAPII, total H3 and 5metC and alternative splicing arrays from two cell lines, we have analyzed the combinatorial code of their binding to chromatin in relation to the alternative splicing patterns between two cell lines, MCF7 and MCF10. Using Machine Learning techniques, we identified the changes in chromatin signals that are most significantly associated with splicing regulation between these two cell lines. Moreover, we have built a map of the chromatin signals on the pre-mRNA, that is, a chromatin-based RNA-map, which can explain 606 (68.55%) of the regulated events between MCF7 and MCF10. This chromatin code involves the presence of HP1a, CTCF, AGO1, RNAPII and histone marks around regulated exons and can differentiate patterns of skipping and inclusion. Additionally, we found a significant association of HP1a and CTCF activities around the regulated exons and a putative DNA binding site for HP1alpha. CONCLUSIONS:Our results show that a considerable number of alternative splicing events could have a chromatin-dependent regulation involving the association of HP1a and CTCF near regulated exons. Additionally, we find further evidence for the involvement of HP1a and AGO1 in chromatin-related splicing regulation., This work was partly supported by the European Alternative Splicing Network (EURASNET). Additionally, E.A, N.B, A.P. and E.E were supported by grants BIO2011-23920 and CSD2009-00080 from MINECO (Spanish Government) and by a grant from the Sandra Ibarra Foundation for Cancer; A.R.K. was supported by grants from the Agencia Nacional de Promoción de Ciencia y Tecnología of Argentina, the University of Buenos Aires, the Howard Hughes Medical Institute; and M.A. by a short term fellowships from EMBO, the Journal of Cell Science and UICC.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A semi-supervised approach uncovers thousands of intragenic enhancers differentially activated in human cells

  • González-Vallinas Rostes, Juan, 1983-
  • Pagès Pinós, Amadís
  • Singh, Babita, 1986-
  • Eyras Jiménez, Eduardo
Background. Transcriptional enhancers are generally known to regulate gene transcription from afar. Their activation involves a series of changes in chromatin marks and recruitment of protein factors. These enhancers may also occur inside genes, but how many may be active in human cells and their effects on the regulation of the host gene remains unclear./nResults. We describe a novel semi-supervised method based on the relative enrichment of chromatin signals between 2 conditions to predict active enhancers. We applied this method to the tumoral K562 and the normal GM12878 cell lines to predict enhancers that are differentially active in one cell type. These predictions show enhancer-like properties according to positional distribution, correlation with gene expression and production of enhancer RNAs. Using this model, we predict 10,365 and 9777 intragenic active enhancers in K562 and GM12878, respectively, and relate the differential activation of these enhancers to expression and splicing differences of the host genes./nConclusions. We propose that the activation or silencing of intragenic transcriptional enhancers modulate the regulation of the host gene by means of a local change of the chromatin and the recruitment of enhancer-related factors that may interact with the RNA directly or through the interaction with RNA binding proteins. Predicted enhancers are available at http://regulatorygenomics.upf.edu/Projects/enhancers.html., The authors would like to thank E. Furlong, Y. Barash, B. Blencowe and U. Braunschweig for useful discussions. This work was supported by grants from Plan Nacional I + D (BIO2011-23920) and Consolider (CSD2009-00080) from MINECO (Spanish Government), and by the Sandra Ibarra Foundation for Cancer (FSI 2013). JGV and BS were supported FPI grants from the MINECO (Spanish Government) BES-2009-018064 and BES-2012-052683, respectively.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Regulation of FAS exon definition and apoptosis by the ewing sarcoma protein

  • Paronetto, Maria Paola
  • Bernardis, Isabella
  • Volpe, Elisabetta
  • Bechara, Elias
  • Sebestyén, Endre
  • Eyras Jiménez, Eduardo
  • Valcárcel, J. (Juan)
The Ewing sarcoma protein EWS is an RNA and DNA binding protein implicated in transcription, pre-mRNA splicing, and DNA damage response. Using CLIP-seq, we identified EWS RNA binding sites in exonic regions near 5′ splice sites. A prominent target was exon 6 of the FAS/CD95 receptor, which is alternatively spliced to generate isoforms with opposing activities in programmed cell death. Depletion and overexpression experiments showed that EWS promotes exon 6 inclusion and consequently the synthesis of the proapoptotic FAS/CD95 isoform, whereas an EWS-FLI1 fusion protein characteristic of Ewing sarcomas shows decreased activity. Biochemical analyses revealed that EWS binding promotes the recruitment of U1snRNP and U2AF65 to the splice sites flanking exon 6 and therefore exon definition. Consistent with a role for EWS in the regulation of programmed cell death, cells depleted of EWS show decreased sensitivity to FAS-induced apoptosis, and elevated EWS expression enhances apoptosis in EWS-haploinsufficient Ewing sarcoma cells., M.P.P. was supported by a fellowship from the HFSP. This project was supported by Fundación Botín, Fundación Sandra Ibarra (FSI2013), the European Union Sixth Framework Programme under grant agreement Nr. LSHG-CT-2005-518238-V (EURASNET), the Spanish Ministry of Economy and Competitiveness (grant no. CSD2009-00080, Consolider RNAREG/BFU2011-29583 / BIO2011-23920), and AIRC (Grant MFAG 11658). We also acknowledge support of the Spanish Ministry of Economy and Competitiveness, “Centro de Excelencia Severo Ochoa 2013-2017” (SEV-2012-0208)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The translational landscape of the splicing factor SRSF1 and its role in mitosis

  • Maslon, Magdalena M.
  • Heras, Sara R.
  • Bellora Pereyra, Nicolás
  • Eyras Jiménez, Eduardo
  • Cáceres, Javier F.
The shuttling serine/arginine rich (SR) protein SRSF1 (previously known as SF2/ASF) is a splicing regulator that also activates translation in the cytoplasm. In order to dissect the gene network that is translationally regulated by SRSF1, we performed a high-throughput deep sequencing analysis of polysomal fractions in cells overexpressing SRSF1. We identified approximately 1500 mRNAs that are translational targets of SRSF1. These include mRNAs encoding proteins involved in cell cycle regulation, such as spindle, kinetochore, and M phase proteins, which are essential for accurate chromosome segregation. Indeed, we show that translational activity of SRSF1 is required for normal mitotic progression. Furthermore, we found that mRNAs that display alternative splicing changes upon SRSF1 overexpression are also its translational targets, strongly suggesting that SRSF1 couples pre-mRNA splicing and translation. These data provide insights on the complex role of SRSF1 in the control of gene expression at multiple levels and its implications in cancer., MRC Core Funding Sara R Heras, Javier F Cáceres. Wellcome Trust Senior Investigator Award Grant 095518/Z/11/Z Magdalena M Maslon, Javier F Cáceres. Marie Curie IntraEuropean fellowship Sara R Heras. Consolider RNAReg CSD2009-00080 Nicolas Bellora, Eduardo Eyras. Ministerio de Economia y Competitividad BIO2011-23920 Nicolas Bellora, Eduardo Eyras. Sandra Ibarra Foundation FSI2011-35 Nicolas Bellora, Eduardo Eyras.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Predictive models of gene regulation from high-throughput epigenomics data

  • Althammer, Sonja Daniela
  • Pagès Pinós, Amadís
  • Eyras Jiménez, Eduardo
The epigenetic regulation of gene expression involves multiple factors. The synergistic or antagonistic action of these factors has suggested the existence of an epigenetic code for gene regulation. Highthroughput sequencing (HTS) provides an opportunity to explore this code and to build quantitative models of gene regulation based on epigenetic differences between specific cellular conditions. We describe a new computational framework that facilitates the systematic integration of HTS epigenetic data. Our method relates epigenetic signals to expression by comparing two conditions. We show its effectiveness by building a model that predicts with high accuracy significant expression differences between two cell lines, using epigenetic data from the ENCODE project. Our analyses provide evidence for a degenerate epigenetic code, which involves multiple genic regions. In particular, signal changes at the 1st exon, 1st intron, and downstream of the polyadenylation site are found to associate strongly with expression regulation. Our analyses also show a different epigenetic code for intron-less and intron-containing genes. Our work provides a general methodology to do integrative analysis of epigenetic differences between cellular conditions that can be applied to other studies, like cell differentiation or carcinogenesis., This work was supported by Grants BIO2011-23920 and CSD2009-00080 from the Spanish Ministry of/nScience and by the Sandra Ibarra Foundation. S. Althammer was supported by an FI grant from the Generalitat de Catalunya
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A quantitative profiling tool for diverse genomic data types reveals potential associations between chromatin and Pre-mRNA processing

  • Kremsky, Isaac Jacob, 1983-
  • Bellora Pereyra, Nicolás
  • Eyras Jiménez, Eduardo
High-throughput sequencing, and genome-based datasets in general, are often represented as profiles centered at reference points to study the association of protein binding and other signals to particular regulatory mechanisms. Although these profiles often provide compelling evidence of these associations, they do not provide a quantitative assessment of the enrichment, which makes the comparison between signals and conditions difficult. In addition, a number of biases can confound profiles, but are rarely accounted for in the tools currently available. We present a novel computational method, ProfileSeq, for the quantitative assessment of biological profiles to provide an exact, nonparametric test that specific regions of the test profile have higher or lower signal densities than a control set. The method is applicable to high-throughput sequencing data (ChIP-Seq, GRO-Seq, CLIP-Seq, etc.) and to genome-based datasets (motifs, etc.). We validate ProfileSeq by recovering and providing a quantitative assessment of several results reported before in the literature using independent datasets. We show that input signal and mappability have confounding effects on the profile results, but that normalizing the signal by input reads can eliminate these biases while preserving the biological signal. Moreover, we apply ProfileSeq to ChIP-Seq data for transcription factors, as well as for motif and CLIP-Seq data for splicing factors. In all examples considered, the profiles were robust to biases in mappability of sequencing reads. Furthermore, analyses performed with ProfileSeq reveal a number of putative relationships between transcription factor binding to DNA and splicing factor binding to pre-mRNA, adding to the growing body of evidence relating chromatin and pre-mRNA processing. ProfileSeq provides a robust way to quantify genome-wide coordinate-based signal. Software and documentation are freely available for academic use at https://bitbucket.org/regulatorygenomicsupf/profileseq/., Support was provided by an Initial Training Network grant RNPNet (289007) from the European/nCommission [http://ec.europa.eu/research/mariecurieactions/]; grants BIO2011-23920 and/nCSD2009-00080 from Ministerio de Economía y Competitividad (MINECO) from the Spanish/nGovernment [http://www.mineco.gob.es/portal/site/mineco/]; and Fundación Sandra Ibarra de/nSolidaridad Frente al Cáncer [http://www.fundacionsandraibarra.org/]
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Detection of recurrent alternative splicing switches in tumor samples reveals novel signatures of cancer

  • Sebestyén, Endre
  • Zawisza, Michal
  • Eyras Jiménez, Eduardo
The determination of the alternative splicing isoforms expressed in cancer is fundamental for the development of tumor-specific molecular targets for prognosis and therapy, but it is hindered by the heterogeneity of tumors and the variability across patients. We developed a new computational method, robust to biological and technical variability, which identifies significant transcript isoform changes across multiple samples. We applied this method to more than 4000 samples from the The Cancer Genome Atlas project to obtain novel splicing signatures that are predictive for nine different cancer types, and find a specific signature for basal-like breast tumors involving the tumor-driver CTNND1. Additionally, our method identifies 244 isoform switches, for which the change occurs in the most abundant transcript. Some of these switches occur in known tumor drivers, including PPARG, CCND3, RALGDS, MITF, PRDM1, ABI1 and MYH11, for which the switch implies a change in the protein product. Moreover, some of the switches cannot be described with simple splicing events. Surprisingly, isoform switches are independent of somatic mutations, except for the tumor-suppressor FBLN2 and the oncogene MYH11. Our method reveals novel signatures of cancer in terms of transcript isoforms specifically expressed in tumors, providing novel potential molecular targets for prognosis and therapy. Data and software are available at: http://dx.doi.org/10.6084/m9.figshare.1061917 and https://bitbucket.org/regulatorygenomicsupf/iso-ktsp., Ministerio de Ciencia e Innovación of Spain [BIO2011-23920]; Consolider RNAREG [CSD2009-00080]; Sandra Ibarra Foundation for Cancer [FSI2013]. Funding for open access charge: Ministerio de Ciencia e Innovación of Spain [BIO2011-23920]; Consolider RNAREG [CSD2009-00080]; Sandra Ibarra Foundation for Cancer [FSI2013]